New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management

New FDA warnings on NSAIDs and COX-2s will cause a return to basics for pain management.

All Rx NSAIDs will carry a new boxed warning about GI and cardiovascular risk. You'll have to dispense a new Med Guide.

Celebrex (celecoxib) will also have a Medication Guide and boxed warning...plus clinical trial data on cardiovascular risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote